Teicoplanina Sandoz 200 mg polvere e solvente per soluzione iniettabile o infusione o soluzione orale
CRCFC-TEICO.SA.2022
Phase 2 small_molecule active
Quick answer
Teicoplanina Sandoz 200 mg polvere e solvente per soluzione iniettabile o infusione o soluzione orale for cystic fibrosis associated to persistent Staphylococcus aureus (including MRSA) infection is a Phase 2 program (small_molecule) at Verona Pharma Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Verona Pharma Ireland Limited
- Indication
- cystic fibrosis associated to persistent Staphylococcus aureus (including MRSA) infection
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active